Lates News

Vivos Therapeutics (VVOS.US): The revenue for the third quarter of 2025 reached $6.783 million, compared to $3.86 million in the previous period and an expected value of $4.427 million. Earnings per share were -$0.49, compared to -$0.40 in the previous period and an expected value of -$0.51.